Louis-Philippe Boulet
Affiliations: | Universite Laval (Canada) |
Area:
Recreation, Animal Physiology Biology, Public HealthGoogle:
"Louis-Philippe Boulet"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Boulet LP, Abbott C, Brusselle G, et al. (2024) Baseline characteristics and ICS/LAMA/LABA response in asthma: analyses from the CAPTAIN study. The Journal of Allergy and Clinical Immunology. in Practice |
| Klein M, Plante S, Boulay MÈ, et al. (2023) Discrepancy in the suppressive function of regulatory T cells in allergic asthmatic vs. allergic rhinitis subjects upon low-dose allergen challenges. Frontiers in Allergy. 4: 1296601 |
| Shin S, Whitmore GA, Boulet LP, et al. (2023) Anticipating undiagnosed asthma in symptomatic adults with normal pre- and post-bronchodilator spirometry: a decision tool for bronchial challenge testing. Bmc Pulmonary Medicine. 23: 496 |
| Wechsler ME, Scelo G, Larenas-Linnemann DES, et al. (2023) Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma. American Journal of Respiratory and Critical Care Medicine |
| Gerstein E, Bierbrier J, Whitmore GA, et al. (2023) Impact of Undiagnosed COPD and Asthma on Symptoms, Quality of Life, Healthcare Utilization and Work Productivity. American Journal of Respiratory and Critical Care Medicine |
| Scelo G, Torres-Duque CA, Maspero J, et al. (2023) Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry. Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology |
| Levy ML, Bateman ED, Allan K, et al. (2023) Global access and patient safety in the transition to environmentally friendly respiratory inhalers: the Global Initiative for Asthma perspective. Lancet (London, England) |
| Bousquet J, Shamji MH, Anto JM, et al. (2023) Patient-centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA-EAACI approach. Allergy |
| Corren J, Brightling CE, Boulet LP, et al. (2023) Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond. The European Respiratory Journal. 61 |
| Sousa-Pinto B, Jácome C, Pereira AM, et al. (2023) Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study. The Lancet. Digital Health |